欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/V/0277/001
药品名称
Poulvac AE
活性成分
Avian Encephalomyelitis Virus 3.1 IU
剂型
Oral liquid
上市许可持有人
Zoetis Deutschland GmbH Schellingstrasse 1 10785 Berlin
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Denmark (DK)
Portugal (PT)
Bulgaria (BG)
Czechia (CZ)
Slovakia (SK)
Luxembourg (LU)
Austria (AT)
Spain (ES)
Italy (IT)
Poland (PL)
Latvia (LV)
Lithuania (LT)
Estonia (EE)
Hungary (HU)
Slovenia (SI)
United Kingdom (Northern Ireland) (XI)
Poulvac AE Lyophilisate for Suspension in Drinking Water
许可日期
2008/04/05
最近更新日期
2024/11/27
药物ATC编码
QI01AD02 avian encephalomyelitis virus
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
Product information
Date of last change:2025/01/28
Final PL
|
2024_02_15_Poulvac_AE___Gebrauchsinformation___CLEAN_DE
Date of last change:2024/09/06
Final Labelling
|
2024_02_15_Poulvac_AE___Kennzeichnung_CLEAN_DE
Date of last change:2024/09/06
Final SPC
|
2024_02_15_Poulvac_AE_Fachinformation_CLEAN_DE
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase